• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估子宫内膜癌和卵巢癌手术治疗中的医院容量:一项波兰基于人群的研究。

Assessment of Hospital Volume in the Surgical Management of Endometrial and Ovarian Cancer: A Polish Population-Based Study.

机构信息

Department of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

National Health Fund, Warsaw, Poland.

出版信息

Med Sci Monit. 2023 Jan 18;29:e938776. doi: 10.12659/MSM.938776.

DOI:10.12659/MSM.938776
PMID:36650732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9875547/
Abstract

BACKGROUND Surgery is a cornerstone in management of ovarian and endometrial cancer. The European Society of Gynecological Oncology introduced quality indicators to improve management of these cancers. The optimal annual number of surgeries per unit was established for high-quality surgical treatment. MATERIAL AND METHODS The database of the National Health Fund on surgical management of endometrial and ovarian cancer was analyzed. Patients treated between 2017 and 2020 were included. Departments where patients underwent surgery were divided according to number of surgeries performed per year in endometrial cancer: ≥80, 79-50, 49-20, 19-0; and ovarian cancer: ≥100, 99-50, 49-20, 19-0. Optimal number of surgeries per center was defined as at least 100 and 80 surgeries per year in ovarian and endometrial cancer, respectively. RESULTS Totally, there were 22 325 surgeries in 316 units and 10 381 surgeries in 251 units due to endometrial and ovarian cancer, respectively. Most surgeries in endometrial cancer (n=15 077; 67.5%) and ovarian cancer (n=9642; 92.88%) were performed in departments that did not meet optimal criteria in number of surgeries. Between 2017 and 2019, an increasing trend in number of surgeries per year in endometrial and ovarian cancer was found. In 2020, there was a decrease in the number of surgeries by 7.8% (n=453) and 8.6% (n=234) in endometrial and ovarian cancer, respectively. CONCLUSIONS In Poland, surgical treatment of ovarian and endometrial cancer is decentralized. Most cancer patients underwent surgery in low-volume general gynecologic departments. The COVID-19 pandemic impaired cancer management, leading to a decreased number of surgeries.

摘要

背景

手术是卵巢癌和子宫内膜癌治疗的基石。欧洲妇科肿瘤学会引入了质量指标,以改善这些癌症的治疗管理。已经为高质量手术治疗确定了每个单位每年最佳手术数量。

材料和方法

分析了国家卫生基金(National Health Fund)关于子宫内膜癌和卵巢癌手术管理的数据库。纳入了 2017 年至 2020 年期间接受治疗的患者。根据每年进行的手术数量将进行手术的科室在子宫内膜癌中分为以下几类:≥80、79-50、49-20、19-0;在卵巢癌中分为:≥100、99-50、49-20、19-0。将每个中心的最佳手术数量定义为卵巢癌和子宫内膜癌分别至少 100 次和 80 次手术。

结果

共有 316 个科室进行了 22325 次手术,251 个科室进行了 10381 次手术,分别用于治疗子宫内膜癌和卵巢癌。大多数子宫内膜癌(n=15077;67.5%)和卵巢癌(n=9642;92.88%)手术都是在未达到手术数量最佳标准的科室进行的。在 2017 年至 2019 年期间,每年的手术数量在子宫内膜癌和卵巢癌中都呈上升趋势。2020 年,这两种癌症的手术数量分别减少了 7.8%(n=453)和 8.6%(n=234)。

结论

在波兰,卵巢癌和子宫内膜癌的手术治疗较为分散。大多数癌症患者在低容量的普通妇科科室接受手术。COVID-19 大流行影响了癌症管理,导致手术数量减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb90/9875547/588ca7388bd3/medscimonit-29-e938776-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb90/9875547/588ca7388bd3/medscimonit-29-e938776-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb90/9875547/588ca7388bd3/medscimonit-29-e938776-g001.jpg

相似文献

1
Assessment of Hospital Volume in the Surgical Management of Endometrial and Ovarian Cancer: A Polish Population-Based Study.评估子宫内膜癌和卵巢癌手术治疗中的医院容量:一项波兰基于人群的研究。
Med Sci Monit. 2023 Jan 18;29:e938776. doi: 10.12659/MSM.938776.
2
Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'.COVID-19 大流行对接受手术治疗的妇科恶性肿瘤患者的影响:一项基于荷兰人群的研究,使用了来自“荷兰妇科肿瘤学审计”的数据。
Gynecol Oncol. 2022 May;165(2):330-338. doi: 10.1016/j.ygyno.2022.02.013. Epub 2022 Feb 22.
3
Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis.COVID-19 大流行对妇科癌症诊断和治疗的影响:单中心分析。
Medicina (Kaunas). 2022 Dec 16;58(12):1862. doi: 10.3390/medicina58121862.
4
Predictors of comprehensive surgical treatment in patients with ovarian cancer.卵巢癌患者综合手术治疗的预测因素。
Cancer. 2007 May 15;109(10):2031-42. doi: 10.1002/cncr.22604.
5
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.机器人辅助微创手术在妇科和泌尿外科肿瘤学中的应用:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.
6
Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.保留生育功能手术治疗宫颈癌、子宫内膜癌和卵巢癌患者。
J Minim Invasive Gynecol. 2021 Mar;28(3):392-402. doi: 10.1016/j.jmig.2020.12.027. Epub 2020 Dec 26.
7
The impact of the COVID-19 pandemic on the number of brain tumor surgeries in Poland: A national database study.COVID-19 大流行对波兰脑肿瘤手术数量的影响:一项全国数据库研究。
Adv Clin Exp Med. 2023 Nov;32(11):1299-1309. doi: 10.17219/acem/161726.
8
New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review.新的靶向治疗和治疗宫颈癌、子宫内膜癌和卵巢癌的联合治疗方案:年度回顾。
Curr Oncol. 2022 Apr 17;29(4):2835-2847. doi: 10.3390/curroncol29040231.
9
[Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].23例同时性双原发性妇科恶性肿瘤的临床分析
Zhonghua Fu Chan Ke Za Zhi. 2022 May 25;57(5):352-360. doi: 10.3760/cma.j.cn112141-20220214-00086.
10
Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective.COVID-19 大流行期间妇科癌症的管理:南亚视角。
Cancer Control. 2022 Jan-Dec;29:10732748221119349. doi: 10.1177/10732748221119349.

引用本文的文献

1
The landscape of ovarian cancer surgery in Italy: Data from PNE.意大利卵巢癌手术的概况:来自PNE的数据。
Eur J Obstet Gynecol Reprod Biol X. 2025 Mar 27;26:100383. doi: 10.1016/j.eurox.2025.100383. eCollection 2025 Jun.
2
Endometrial Cancer - Long-Term Survival in Certified Cancer Centers and Non-Certified Hospitals: Comparative Analysis Based on a Large German Retrospective Cohort Study (WiZen).子宫内膜癌——认证癌症中心与非认证医院的长期生存率:基于德国一项大型回顾性队列研究(WiZen)的比较分析
Geburtshilfe Frauenheilkd. 2024 Oct 1;84(10):979-988. doi: 10.1055/a-1869-2060. eCollection 2024 Oct.
3
Range of Resection in Endometrial Cancer-Clinical Issues of Made-to-Measure Surgery.

本文引用的文献

1
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.欧洲妇科肿瘤学会子宫内膜癌手术治疗质量指标。
Int J Gynecol Cancer. 2021 Dec;31(12):1508-1529. doi: 10.1136/ijgc-2021-003178. Epub 2021 Nov 18.
2
An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.一项关于卵巢癌初诊治疗的意大利全国性调查。充耳不闻者最聋。
J Cancer. 2021 May 27;12(15):4443-4454. doi: 10.7150/jca.57894. eCollection 2021.
3
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
子宫内膜癌的切除范围——定制手术的临床问题
Cancers (Basel). 2024 May 11;16(10):1848. doi: 10.3390/cancers16101848.
ESGO/ESTRO/ESP 指南:子宫内膜癌患者管理
Radiother Oncol. 2021 Jan;154:327-353. doi: 10.1016/j.radonc.2020.11.018.
4
PARP inhibitors in the treatment of ovarian cancer: a review.聚腺苷二磷酸核糖聚合酶抑制剂在卵巢癌治疗中的应用:综述。
Curr Opin Obstet Gynecol. 2021 Feb 1;33(1):1-6. doi: 10.1097/GCO.0000000000000675.
5
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?免疫检查点抑制剂:子宫内膜癌患者的一个有前景的选择?
J Clin Med. 2020 Jun 3;9(6):1721. doi: 10.3390/jcm9061721.
6
Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.欧洲妇科肿瘤学会(ESGO)晚期卵巢癌手术质量指标:2020年更新
Int J Gynecol Cancer. 2020 Apr;30(4):436-440. doi: 10.1136/ijgc-2020-001248. Epub 2020 Feb 20.
7
Global, Regional, and National Burden of Endometrial Cancer, 1990-2017: Results From the Global Burden of Disease Study, 2017.1990 - 2017年全球、区域和国家子宫内膜癌负担:全球疾病负担研究2017年结果
Front Oncol. 2019 Dec 19;9:1440. doi: 10.3389/fonc.2019.01440. eCollection 2019.
8
The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality.服务集中化对卵巢癌治疗延迟的影响:一项过程质量研究。
Int J Qual Health Care. 2017 Oct 1;29(6):810-816. doi: 10.1093/intqhc/mzx107.
9
Global trends and predictions in ovarian cancer mortality.全球卵巢癌死亡率的趋势和预测。
Ann Oncol. 2016 Nov;27(11):2017-2025. doi: 10.1093/annonc/mdw306. Epub 2016 Sep 5.
10
Centralisation of services for gynaecological cancers - a Cochrane systematic review.妇科癌症服务的集中化——一项 Cochrane 系统评价。
Gynecol Oncol. 2012 Aug;126(2):286-90. doi: 10.1016/j.ygyno.2012.04.012. Epub 2012 Apr 13.